Apheresis Market worth $4.41billion by 2031 | MarketsandMarkets
DELRAY BEACH, Fla., June 5, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Apheresis Market is projected to grow from about USD 3.02 billion in 2026 to USD 4.41 billion by 2031, at a CAGR of 7.9%.
Browse 380 market data Tables and 270 Figures spread through 500 Pages and in-depth TOC on "Apheresis Market - Global Forecast to 2031"
Apheresis Market Size & Forecast:
- Market Size Available for Years: 2025–2031
- 2026 Market Size: USD 3.02 billion
- 2031 Projected Market Size: USD 4.41 billion
- CAGR (2026–2031): 7.9%
Apheresis Market Trends & Insights:
- Apheresis disposables are expected to dominate the offering segment, with an 83.4% share in 2025.
- Donor apheresis is expected to register the highest CAGR of 58.2% during the forecast period.
- Centrifugation is projected to hold 79.8% of the market during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950
The apheresis market is experiencing significant growth due to several key factors. The rising prevalence of autoimmune and neurological diseases has increased the need for therapeutic apheresis procedures. Additionally, the growing global population, along with an increase in surgical procedures and trauma cases, has increased the need for blood components and plasma collection. In addition, the expansion of healthcare in developing regions and wider access to hospitals and therapies have created new markets for apheresis. Technological advancements are also playing a major role through more automated and convenient apheresis machines, which have boosted adoption in the hospital and blood bank sectors. Collectively, these trends are fueling steady growth in the apheresis industry worldwide.
By type, the donor apheresis segment is expected to register the highest CAGR during the forecast period.
Based on type, the apheresis market can be classified into two segments: donor apheresis and therapeutic apheresis. The donor apheresis segment is anticipated to register a high CAGR throughout the forecast period owing to the growing demand for plasma and blood components globally, increasing awareness about voluntary blood donations, and increasing need for source plasma in the development of plasma-based products.

